New clinical trial data shows that the Johnson & Johnson vaccine is able to give 66% protection against COVID in one dose - with an 85% efficiency at the standard double-dose.
Craig Rhodes, EMEA Industry Lead for Artificial Intelligence Healthcare and Life Science at NVIDIA, explores how bovine tuberculosis (bTB) can be monitored and treated more effectively and efficiently using Artificial Intelligence (AI).
Harjott Atrii, Executive Vice President and Global Head, Digital Foundation Services, at Zensar, explains how cities can embark on a smart/digital journey.
The new Horizon Europe programme will pick up where Horizon 2020 left off, with five main missions - cancer, climate change, marine environment, smart cities and food security.
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
Professor Dirk Schoenmaker discusses how the world of finance is just beginning to acknowledge to the idea of sustainability - here, he explores what the future could bring.
Glen Ocsko, head of local government at Made Tech, discusses why local council departments do not need to live in constant fear of technological innovation.
Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.
Yesterday, President Biden signed a slew of executive orders on climate change, describing the new proposals as a way to fight an "existential threat".
Professor Dr Tineke Lambooy discusses why granting legal personhood to entities of nature could enable society to protect biodiversity for future generations.